KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

AbCellera Biologics (ABCL) Other Non Operating Income (2020 - 2023)

AbCellera Biologics (ABCL) has disclosed Other Non Operating Income for 4 consecutive years, with $10.5 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Other Non Operating Income rose 181.13% year-over-year to $10.5 million, compared with a TTM value of $14.2 million through Dec 2023, up 449.94%, and an annual FY2024 reading of $62.3 million, up 339.97% over the prior year.
  • Other Non Operating Income was $10.5 million for Q4 2023 at AbCellera Biologics, up from $2.0 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $10.5 million in Q4 2023 and bottomed at -$12.9 million in Q4 2022.
  • Average Other Non Operating Income over 4 years is $771875.0, with a median of $1.8 million recorded in 2022.
  • Peak annual rise in Other Non Operating Income hit 414.49% in 2021, while the deepest fall reached 754.27% in 2021.
  • Year by year, Other Non Operating Income stood at $8.3 million in 2020, then tumbled by 234.17% to -$11.1 million in 2021, then dropped by 16.38% to -$12.9 million in 2022, then surged by 181.13% to $10.5 million in 2023.
  • Business Quant data shows Other Non Operating Income for ABCL at $10.5 million in Q4 2023, $2.0 million in Q3 2023, and -$1.8 million in Q2 2023.